2.13
前日終値:
$2.12
開ける:
$2.15
24時間の取引高:
10,369
Relative Volume:
0.05
時価総額:
$14.71M
収益:
$3.19M
当期純損益:
$-10.42M
株価収益率:
-0.06
EPS:
-35.4757
ネットキャッシュフロー:
$-10.65M
1週間 パフォーマンス:
-11.57%
1か月 パフォーマンス:
-16.08%
6か月 パフォーマンス:
+7.00%
1年 パフォーマンス:
-52.23%
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
INBS を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
INBS
Intelligent Bio Solutions Inc
|
2.13 | 14.71M | 3.19M | -10.42M | -10.65M | -35.48 |
![]()
ABT
Abbott Laboratories
|
126.34 | 221.85B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
96.76 | 142.24B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
370.86 | 140.07B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
93.06 | 118.98B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
68.63 | 40.31B | 5.72B | 4.17B | 259.90M | 6.97 |
Intelligent Bio Solutions Inc (INBS) 最新ニュース
Intelligent Bio Solutions to Offer Additional Common Stock By Investing.com - Investing.com Australia
Intelligent Bio Solutions to Offer Additional Common Stock - Investing.com
Intelligent Bio Solutions to Participate in the iAccess Virtual Best Ideas Spring Conference on March 25th and 26th - The Manila Times
INBSIntelligent Bio Solutions Inc Latest Stock News & Market Updates - StockTitan
Intelligent Bio Solutions closes public offering of common stock - Medical Buyer
Intelligent Bio Solutions Inc (INBS) Should Be Considered For The Next Few Weeks - Stocks Register
Navient finalizes sale of Government Services business - The Manila Times
Intelligent Bio Solutions shares fall on proposed offering of common stock - MSN
Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter's Option to Purchase Additional Shares of Common Stock - The Manila Times
Intelligent Bio Solutions Inc. Closes $3 Million Public Offering of Common Stock - Nasdaq
Can This $3M Capital Raise Transform Intelligent Bio Solutions' Future? - StockTitan
Intelligent Bio Solutions announces pricing of $2.6 million public offering; shares fall - MSN
Intelligent Bio Solutions sets $2 public stock offering By Investing.com - Investing.com Nigeria
Intelligent Bio Solutions Inc. Announces $2.6 Mln Common Stock Offering Pricing - Nasdaq
Intelligent Bio Solutions sets $2 public stock offering - Investing.com
Intelligent Bio Solutions Inc. Announces Pricing of $2.6 Million Public Offering of Common Stock - The Manila Times
Can This $2.6M Biotech Offering Signal Growth Potential for Intelligent Bio Solutions? - StockTitan
Intelligent Bio Solutions Announces Proposed Public Offering Of Common Stock -February 19, 2025 at 05:50 pm EST - Marketscreener.com
W&T Offshore Announces Timing of Fourth Quarter and Full Year 2024 Earnings Release and Conference Call - The Manila Times
Intelligent Bio Solutions Inc. Announces Underwritten Public Offering of Common Stock - Nasdaq
Is This Biotech's Latest Stock Offering a Red Flag for Investors? - StockTitan
Pre-market Movers: TNXP, INBS, SMMT, NDRA... - RTTNews
Biological Safety Testing Services Market Size to Hit USD 10.82 Billion by 2034 - BioSpace
Intelligent Bio Solutions Second Quarter 2025 Earnings: US$0.50 loss per share (vs US$2.07 loss in 2Q 2024) - Yahoo Finance
Intelligent Bio : Fiscal Second Quarter 2025 Press Release -February 14, 2025 at 09:55 pm EST - Marketscreener.com
Intelligent Bio Solutions Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2024 - Marketscreener.com
Intelligent Bio Solutions Inc Reports Q2 Revenue of $0.61 Millio - GuruFocus.com
Intelligent Bio Solutions Inc. (INBS) reports earnings - Quartz
Intelligent Bio Solutions Announces Fiscal Q2 2025 Financial Results and Key Operational Achievements - The Manila Times
INTELLIGENT BIO SOLUTIONS INC. SEC 10-Q Report - TradingView
Intelligent Bio releases shareholder letter on 2024 growth, 2025 strategy - Yahoo Finance
Intelligent Bio Solutions Plans U.S. Market Entry in 2025 - TipRanks
Intelligent Bio Solutions Releases Shareholder Letter Detailing 2024 Growth and 2025 U.S. Expansion Strategy - The Manila Times
INBS’s 2023 Market Dance: Up 51.43% – Time to Invest? - The InvestChronicle
Intelligent Bio Solutions Inc. Outlines Growth and U.S. Expansion Plans in Shareholder Letter - Nasdaq
ForexTV | Small Business Resources - ForexTV.com
Intelligent Bio Solutions Hits 148% Growth, Eyes $15B Drug Testing Market with FDA Filing - StockTitan
Intelligent Bio Solutions Inc (NASDAQ: INBS): Can A Stock Be 51.43% Higher Year-To-Date And Still Be A Loser? - Marketing Sentinel
Intelligent Bio Solutions Partners with Avon Freight Group - TipRanks
Intelligent Bio Solutions Inc Reports Q2 EPS of -$0.32, Revenue Falls Short at $0.61 Million - GuruFocus.com
Intelligent Bio Solutions Expands with UK Partnership, Driving Global Growth Ahead of Planned U.S. Launch - The Manila Times
EXCLUSIVE: Intelligent Bio Solutions Expects To Record Increased Profitability In Q2 On Higher-Margin Sales - AOL
Intelligent Bio Solutions expects to achieve 32.6% Gross Profit Expansion and Increased Profitability on Higher-Margin Sales - The Manila Times
Intelligent Bio Solutions Inc. Reports 32.6% Surge in Gross Profit Amid Strategic Growth Initiatives - Nasdaq
Q2 Earnings: This Medical Device Company Just Doubled Its Profit Margins with Recurring Revenue - StockTitan
Intelligent Bio Solutions Expands Fingerprinting System Globally - MSN
Intelligent Bio Solutions Inc. (NASDAQ:INBS) Short Interest Down 5.1% in January - Defense World
Iveda Solutions, Inc. (NASDAQ:IVDAW) Sees Significant Increase in Short Interest - Defense World
Intelligent Bio Solutions Inc (INBS) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):